In the case of metabolic diseases, elevated levels IGFBP-3 could increase risk of T2DM independently of IGF-1 [10]
Homocysteine can either be remethylated back to methionine or diverted into the transsulfuration pathway to produce cysteine (the precursor to glutathione)
[5] Practical Considerations for Clinical Use Anyone considering BPC-157 as part of a health or longevity protocol should approach it with the same framework applied to any emerging therapy: define the target outcome, select the administration route supported by the best evidence for that target, start at a conservative dose, and monitor response systematically rather than anecdotally
This treatment involves the application of a chemical solution, typically containing acids like glycolic acid, salicylic acid, or lactic acid, to exfoliate the top layers of skin
In this first in-elephant proof-of-concept trial, the primary aim was to evaluate the safety of this approach